Which is better, ONC or UTHR?

On the Buffett-Fit framework, BeOne Medicines Ltd. (ONC) currently grades higher than UTHR — 62/100 (D grade) vs 71/100 (B). That said, "better" depends on which framework you trust — ONC wins on Philip Fisher, Peter Lynch, and Joel Greenblatt; UTHR wins on Warren Buffett, Benjamin Graham, Charlie Munger, and Terry Smith. The full pillar breakdown is on this page.

Should I buy ONC or UTHR?

This page is an educational comparison, not investment advice. Both ONC and UTHR are graded against the same Buffett 5-pillar framework (moat, earnings durability, management quality, financial health, valuation) plus six other documented investor frameworks. Read the side-by-side breakdown to see which one matches the criteria you care about most — and always do your own research before making any investment decision.

Is ONC better than UTHR for value investing?

On the Buffett-style value-investing framework, ONC currently grades higher — 71/100 vs 62/100, a 9-point gap. The gap is driven by which pillars each stock passes; the table on this page shows moat, durability, management, financial health, and valuation side-by-side.

What's the difference between ONC and UTHR on Warren Buffett's framework?

Both stocks are evaluated on the same five pillars: economic moat (durable competitive advantage), earnings durability (consistent profitability), management quality (capital allocation), financial health (conservative balance sheet), and valuation (margin of safety). ONC currently scores 62/100 (D grade); UTHR scores 71/100 (B grade). The "Where each wins" section on this page breaks down which pillar each stock dominates.

Which has the stronger moat, ONC or UTHR?

Moat strength is one of the five pillars in the Buffett-Fit score on this page. ONC and UTHR are each scored on ROIC sustainability, gross-margin durability, and qualitative signals like brand strength, switching costs, network effects, and regulatory barriers. The pillar breakdown on this page shows the moat sub-score side-by-side so you can see which one has the more durable competitive advantage.

Which is more undervalued, ONC or UTHR?

Valuation is one of the five Buffett-Fit pillars on this page. Both stocks are scored on owner-earnings yield, price-to-intrinsic-value vs the underlying compounding rate, and the margin of safety relative to a conservative DCF. The valuation sub-score in the table below tells you which one currently trades at a more attractive price relative to its underlying business quality.

Are ONC and UTHR both Healthcare stocks?

Yes — both BeOne Medicines Ltd. (ONC) and United Therapeutics Corporation (UTHR) operate in the Healthcare sector. That makes this a direct sector-peer comparison, which is the apples-to-apples way to use the Buffett-Fit framework: the score weighs each stock against its sector's specific quality and valuation benchmarks (sector-relative bonus), so the cross-stock comparison isn't distorted by inter-sector base-rate differences.

Is this ONC vs UTHR comparison investment advice?

No. This page is an educational pattern-match against documented public frameworks (Buffett, Graham, Fisher, Lynch, Greenblatt, Munger, Smith), not personalised investment advice. The scores reflect how closely each stock matches each framework's documented criteria — they are not buy/hold/sell recommendations. Always do your own research and consult a licensed financial adviser for personalised advice.

Stock comparison

BeOne Medicines

United Therapeutics

Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.

ONC

BeOne Medicines

Market cap

$33.15B

Sector

Healthcare

UTHR

United Therapeutics

Market cap

$24.13B

Sector

Healthcare

Overall winner

BeOne Medicines ONC

Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.

Fit scores by strategy

Strategy	ONC	UTHR	Winner
Warren Buffett	62D	71B	UTHR
Benjamin Graham	75D	76B	UTHR
Philip Fisher	84C	76B	ONC
Peter Lynch	75B	62C	ONC
Joel Greenblatt	49D	46D	ONC
Charlie Munger	56D	64C	UTHR
Terry Smith	60D	64C	UTHR

Side-by-side metrics

Metric	ONC	UTHR
Market cap	$33.15B	$24.13B
P/E (TTM)	107.5x	19.2x
EV/EBIT	28.9x	15.2x
ROIC (TTM)	7.73%	18.81%
Gross margin	87.17%	86.58%
Net margin	8.93%	40.61%
Revenue CAGR 5y	45.99%	17.22%
EPS CAGR 5y	67.36%	29.84%
Debt / Equity	0.4x	-
Dividend yield	0.0%	0.0%

Where each one wins

The metrics with the biggest gap between the two - sorted so the most decisive edges read first.

ONC leads on

Revenue CAGR 5y45.99%vs 17.22%+63%
EPS CAGR 5y67.36%vs 29.84%+56%
Market cap$33.15Bvs $24.13B+27%

UTHR leads on

Debt / Equity-vs 0.4x+100%
P/E (TTM)19.2xvs 107.5x+82%
Net margin40.61%vs 8.93%+78%
ROIC (TTM)18.81%vs 7.73%+59%

More like ONC

ONC vs HALO ONC vs LMAT ONC vs RMD ONC vs LLY ONC vs HAE ONC vs IDXX

More like UTHR

UTHR vs HALO UTHR vs LMAT UTHR vs RMD UTHR vs LLY UTHR vs HAE UTHR vs IDXX

Read the full Buffett-Brain analysis for ONC Read the full Buffett-Brain analysis for UTHR

Related on invest-like

Strongest Moat Highest ROIC Warren Buffett strategy Economic Moat

Key terms in this analysis

ROIC Free Cash Flow (FCF)Economic Moat P/E Ratio Margin of Safety Quality Score

Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.

Stock comparison

BeOne Medicines

United Therapeutics

Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.

ONC

BeOne Medicines

Market cap

$33.15B

Sector

Healthcare

UTHR

United Therapeutics

Market cap

$24.13B

Sector

Healthcare

Overall winner

BeOne Medicines ONC

Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.

Fit scores by strategy

Strategy	ONC	UTHR	Winner
Warren Buffett	62D	71B	UTHR
Benjamin Graham	75D	76B	UTHR
Philip Fisher	84C	76B	ONC
Peter Lynch	75B	62C	ONC
Joel Greenblatt	49D	46D	ONC
Charlie Munger	56D	64C	UTHR
Terry Smith	60D	64C	UTHR

Side-by-side metrics

Metric	ONC	UTHR
Market cap	$33.15B	$24.13B
P/E (TTM)	107.5x	19.2x
EV/EBIT	28.9x	15.2x
ROIC (TTM)	7.73%	18.81%
Gross margin	87.17%	86.58%
Net margin	8.93%	40.61%
Revenue CAGR 5y	45.99%	17.22%
EPS CAGR 5y	67.36%	29.84%
Debt / Equity	0.4x	-
Dividend yield	0.0%	0.0%

Where each one wins

The metrics with the biggest gap between the two - sorted so the most decisive edges read first.

ONC leads on

Revenue CAGR 5y45.99%vs 17.22%+63%
EPS CAGR 5y67.36%vs 29.84%+56%
Market cap$33.15Bvs $24.13B+27%

UTHR leads on

Debt / Equity-vs 0.4x+100%
P/E (TTM)19.2xvs 107.5x+82%
Net margin40.61%vs 8.93%+78%
ROIC (TTM)18.81%vs 7.73%+59%

More like ONC

ONC vs HALO ONC vs LMAT ONC vs RMD ONC vs LLY ONC vs HAE ONC vs IDXX

More like UTHR

UTHR vs HALO UTHR vs LMAT UTHR vs RMD UTHR vs LLY UTHR vs HAE UTHR vs IDXX

Read the full Buffett-Brain analysis for ONC Read the full Buffett-Brain analysis for UTHR

Related on invest-like

Strongest Moat Highest ROIC Warren Buffett strategy Economic Moat

Key terms in this analysis

ROIC Free Cash Flow (FCF)Economic Moat P/E Ratio Margin of Safety Quality Score

Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.